PRKCE and acute myeloid leukemia: PKCε has also been implicated in malignant cell survival (9–12) and in AML cells PKCε has been reported to protect from TRAIL-induced apoptosis and to modulate reactive oxygen species (ROS) homeostasis (13, 14).